Wealth Enhancement Advisory Services
AMED

Wealth Enhancement Advisory Services’s Amedisys AMED Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,958
Closed -$284K – 3588
2025
Q2 		$284K Buy
+2,958
New +$280K ﹤0.01% 2688
2025
Q1 		– Sell
-2,482
Closed -$225K – 2984
2024
Q4 		$225K Buy
+2,482
New +$228K ﹤0.01% 2613
2024
Q2 		– Sell
-2,622
Closed -$242K – 2623
2024
Q1 		$242K Sell
2,622
-336
-11% -$31.5K ﹤0.01% 2063
2023
Q4 		$281K Buy
2,958
+78
+3% +$7.29K ﹤0.01% 1858
2023
Q3 		$269K Buy
+2,880
New +$266K ﹤0.01% 1810
2020
Q4 		– Sell
-6,136
Closed -$1.53M – 216
2020
Q3 		$1.53M Buy
+6,136
New +$1.4M 0.04% 160

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wealth Enhancement Advisory Services's AMED Position: Q3 2025 in Review

Wealth Enhancement Advisory Services sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,958 shares — an estimated $284K sold.

Wealth Enhancement Advisory Services first reported a position in AMED in Q3 2020 and held it in 6 quarters. The position peaked at $1.53M in Q3 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Wealth Enhancement Advisory Services reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 2,958 Amedisys shares in Q3 2025, an estimated $284K.
  • Wealth Enhancement Advisory Services first reported a position in Amedisys in Q3 2020 and held it in 6 quarters.
  • Wealth Enhancement Advisory Services's Amedisys position peaked at $1.53M in Q3 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2025, filed 29 Oct 2025.